These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 35177934)
1. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction]. Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway. Yao X; You G; Zhou C; Zhang D Cancer Manag Res; 2019; 11():9371-9378. PubMed ID: 31807066 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer. Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219 [TBL] [Abstract][Full Text] [Related]
4. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway. Tan LJ; Liu JT; Yang M; Ju T; Zhang YS Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer. Yang J; Ye Z; Mei D; Gu H; Zhang J Cancer Manag Res; 2019; 11():4209-4221. PubMed ID: 31118816 [TBL] [Abstract][Full Text] [Related]
6. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T; Zhu X; Zhu K; Jia F; Li S Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA FGD5-AS1 Promotes Glioma Cell Proliferation, Migration and Invasion by Regulating Wnt/β-Catenin Pathway [Retraction]. Cancer Manag Res; 2023; 15():785-786. PubMed ID: 37529010 [TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p. Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012 [TBL] [Abstract][Full Text] [Related]
9. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway. Tan LJ; Liu JT; Yang M; Ju T; Zhang YS Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1766. PubMed ID: 33660829 [TBL] [Abstract][Full Text] [Related]
10. Retraction Notice to: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC. Li ZT; Zhang X; Wang DW; Xu J; Kou KJ; Wang ZW; Yong G; Liang DS; Sun XY Mol Ther Nucleic Acids; 2022 Jun; 28():594. PubMed ID: 35615007 [TBL] [Abstract][Full Text] [Related]
11. Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction]. Cancer Manag Res; 2022; 14():2105-2106. PubMed ID: 35769227 [TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
14. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway. Wang F; Zhu W; Yang R; Xie W; Wang D Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820 [TBL] [Abstract][Full Text] [Related]
15. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway. Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Zhang H; Liu S; Tang L; Ge J; Lu X Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805 [TBL] [Abstract][Full Text] [Related]
18. LncRNA AZIN1-AS1 ameliorates myocardial ischemia-reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway. Zhang G; Ding L; Sun G; Liu Z; Ou W; Wang B; Sun Y In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):54-68. PubMed ID: 35064471 [TBL] [Abstract][Full Text] [Related]
19. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction]. Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367 [TBL] [Abstract][Full Text] [Related]
20. lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12. Qin M; Meng Y; Luo C; He S; Qin F; Yin Y; Huang J; Zhao H; Hu J; Deng Z; Qiu Y; Hu G; Pan H; Qin Z; Huang Z; Yi T Mol Ther Nucleic Acids; 2021 Sep; 25():37-52. PubMed ID: 34168917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]